Moderna officer Stephen Hoge proposes $8.3M share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Moderna, Inc. (MRNA) officer Stephen Hoge reported a proposed sale of 39,215 common shares, with an aggregate market value of $8,298,104.59 and an approximate sale date of November 17, 2026. The form also records that he acquired 39,215 shares through a cash-paid stock option exercise on November 17, 2026. A Rule 10b5-1 plan adoption date of June 15, 2026 is listed.
For the preceding three months, the form lists sales of 40,294 shares on September 14, 40,281 on September 15, 39,224 on October 14, 39,145 on October 15, and 39,160 on November 16, 2026.
Key Figures
Key Terms
Stock Option Exercise financial
Rule 10b5-1 regulatory
Aggregate Market Value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.